Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment
- PMID: 17085257
- PMCID: PMC2703471
- DOI: 10.1016/j.ccm.2006.07.001
Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment
Abstract
The genetic susceptibility to the development of and variable outcomes in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) has become a topic of great interest in the pulmonary and critical care community. Published studies of variable genetic susceptibility to ALI/ARDS already have identified some important candidate genes and potential gene-environment interactions. This article reviews these recent studies, features of the current approach, and implications for future prevention and treatment in ALI. The challenges and potential contributions of genetic epidemiology to the future prevention and treatment in ALI are discussed.
Figures

References
-
- Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–1349. - PubMed
-
- Hudson L.D., Milberg J.A., Anardi D. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151(2 Pt 1):293–301. - PubMed
-
- Fowler A.A., Hamman R.F., Good J.T. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98(5 Pt 1):593–597. - PubMed
-
- Rubenfeld G.D., Caldwell E., Peabody E. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–1693. - PubMed
-
- Hug C., Lodish H.F. Medicine. Visfatin: a new adipokine. Science. 2005;307(5708):366–367. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical